Osmopharm S.A.

About Osmopharm S.A.

Osmopharm SA is a Swiss pharmaceutical contract manufacturer specialized in the development and production of modified release solid oral form drugs. Osmopharm SA is GMP certified by the Swiss health authority Swissmedic, certificate with European validity thanks to the mutual recognition agreement between EU and Switzerland in accordance with quality and good practices defined by PIC/S (Pharmaceutical Inspection Convention/Co-Operation Scheme). With more than 150 formulations developed, the production capacity reaches 36 tons/month of nonsterile products in solid multi-dose form (control...

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Products from Osmopharm S.A. (100)

Product Acetazolamide

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes acetazolamide. It belongs to diuretic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Allopurinol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes allopurinol. It belongs to antiurolytic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Alprazolam

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes alprazolam. It belongs to anxiolytic category. Bulk physical form: Pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ambroxol HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ambroxol HCI. It belongs to expectorant category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Ambroxol HCI + Doxycicline Hyclate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ambroxol HCI + doxycicline hyclate. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Amitriptyline

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes amitriptyline. It belongs to antidepressant category. Bulk physical form: pellets. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Aspirin

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes aspirin. It belongs to anticoagulant category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Atenolol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes atenolol. It belongs to antihypertensive category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Benproperine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes benproperine. It belongs to antitussive category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Betahistine 2HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes betahistine 2HCI. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Bromopride

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes bromopride. It belongs to antiemetic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Brompheniramine maleate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Brompheniramine Maleate + Phenylephrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Brompheniramine Maleate + Phenylpropanolamine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes brompheniramine maleate + phenylpropanolamine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Caffeine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine. It belongs to CNS stimulant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Caffeine + Dimenhydrinate + Phenylephrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + dimenhydrinate + phenylephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Caffeine + Diphenihydramine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + diphenihydramine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Caffeine + Meclozine + Pyridoxine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes caffeine + meclozine + pyridoxine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Carbetapentane citrate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbetapentane citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Carbinoxamine maleate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate. It belongs to antihistaminic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Carbinoxamine Maleate + Dextromethorphane HBr + Phenylephrine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate + dextromethorphane HBr + phenylephrine HCl. It is a pharmaceutical association. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Carbinoxamine Maleate + Dextromethorphane HBr + Phenylpropanolamine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate + dextromethorphane HBr + phenylpropanolamine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Carbinoxamine Maleate + Phenylephrine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate + phenylephrine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Carbinoxamine Maleate + Phenylpropanolamine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes carbinoxamine maleate + phenylpropanolamine HCl. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Cetirizina

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes cetirizina. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Chlorpheniramine maleate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Chlorpheniramine Maleate + D-Pseudoephedrine SO4

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Chlorpheniramine Maleate + D-Pseudoephedrine SO4 + Paracetamol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + D-pseudoephedrine SO4 + paracetamol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Chlorpheniramine Maleate + Phenylephrine HC

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + phenylephrine HCl. It is a pharmaceutical association. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Chlorpheniramine Maleate + Phenylpropanolamine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes chlorpheniramine maleate + phenylpropanolamine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Clonidine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes clonidine. It belongs to antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Codeine phosfate + Phenylephrine HCl + Chlorpheniramine Maleate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes codeine phosfate + phenylephrine HCl + chlorpheniramine maleate. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Codeine phosphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes codeine phosphate. It belongs to analgesic narcotic / antiussive category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product D-Norpseudoephedrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-norpseudoephedrine HCI. It belongs to anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.

Compare
Product D-Pseudoephedrine + Cetirizina

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine + cetirizina. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product D-Pseudoephedrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine HCI. It belongs to decongestant category. Bulk physical form: pellets, resinates. Final dosage form: caps/ tabs. Contact us for more information.

Compare
Product D-Pseudoephedrine sulphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes D-pseudoephedrine sulphate. It belongs to decongestant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Dextromethorphan HBr

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes dextromethorphan HBr. It belongs to antitussive category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Di hydro ergotoxin mono methane sulfonate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes Di hydro ergotoxin mono methane sulfonate. It belongs to hypertension category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diazepam

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diazepam. It belongs to anxiolytic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diclofenac K

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diclofenac K. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diclofenac Na

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diclofenac Na. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diethylpropion HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diethylpropion HCI. It belongs to anorexic category. Bulk physical form: pellets, powder DC. Final dosage form: caps, tabs. Contact us for more information.

Compare
Product Diltiazem HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diltiazem HCl. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Dimenhydrinate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes dimenhydrinate. It belongs to antiemetic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diphenihydramine HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenihydramine HCl. It belongs to antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diphenydramine HCl + Caffeine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenydramine HCl + caffeine. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Diphenylpiraline HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes diphenylpiraline HCI. It belongs to antihistamine category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Doxycicline base

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes doxycicline base. It belongs to antibacterial category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Doxylamine succinate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes doxylamine succinate. It belongs to antihistamine / hypnotic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Doxylamine succinate + Pyridoxine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes doxylamine succinate + pyridoxine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Etofibrate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes etofibrate. It belongs to antihyperlipoproteinemic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Fenofibrate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes fenofibrate. It belongs to antihyperlipoproteinemic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ferrous Fumarate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous fumarate. It belongs to Fe deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ferrous Sulfate + Folic Acid

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous sulfate + folic acid. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ferrous Sulfate + Folic Acid + Zn

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous sulfate + folic acid + Zn. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ferrous Sulphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ferrous sulphate. It belongs to Fe deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Folic Acid

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes folic acid. It belongs to folate deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Furosemide

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes furosemide. It belongs to diuretic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Ibuprofen

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ibuprofen. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Indomethacin

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes indomethacin. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Isopropamide iodide

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isopropamide iodide. It belongs to antispasmodic / anti ulcer category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Isosorbide dinitrato

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isosorbide dinitrato. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Isosorbide mononitrato

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes isosorbide mononitrato. It belongs to antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product KCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes KCI. It belongs to K deficiency category. Bulk physical form: pellets, microcapsules. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Ketoprofen

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes ketoprofen. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Lansoprazolo

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes lansoprazolo. It belongs to antiulerative category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Mebeverine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes mebeverine HCI. It belongs to antispasmodic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Meclozine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes meclozine. It belongs to anti emetic / antihistaminic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Naftohydrofuryl oxalate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes naftohydrofuryl oxalate. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nicardipina

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nicardipina. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nifedipine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine. It belongs to antianginal / antihypertensive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nifedipine + Atenolol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nifedipine + atenolol. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nitrofurantoin

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitrofurantoin. It belongs to antibacteral category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nitroglycerin

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nitroglycerin. It belongs to antianginal/ vasodiolator coronary category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Norphenephrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes norphenephrine HCI. It is used for treatment of hipotensive states. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Nylidrin / Buphenine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes nylidrin / buphenine. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Omeprazolo

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes omeprazolo. It belongs to antiulcerative category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Oxazepam

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes oxazepam. It belongs to anxiolytic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Oxeladine Citrate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes oxeladine citrate. It belongs to antitussive category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Pancreatine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pancreatine. It belongs to digestive aid category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Paracetamol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes paracetamol. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Pentaerythritol Tetranitrate (PETN)

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentaerythritol tetranitrate (PETN). It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Pentoxifyline

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pentoxifyline. It belongs to vasodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Phentemine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phentemine HCI. It belongs to anorexic category. Bulk physical form: pellets, resinates, powder DC. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Phenylephrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenylephrine HCI. It belongs to decongestant category. Bulk physical form: pellets, resinates, powder DC. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Phenylpropanolamine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenylpropanolamine HCI. It belongs to decongestant / anorexic category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Phenyltoloxamina citrate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes phenyltoloxamina citrate. It belongs to antihistaminic category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Pholedrine Sulphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate. It belongs to antihypotensive (circulatory stimulant) category. Bulk physical form: resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Pholedrine sulphate + Norphenephrine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pholedrine sulphate + norphenephrine HCI. It is a pharmaceutical association. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Piroxicam

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes piroxicam. It belongs to anti-inflammatory category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Propranolol

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes propranolol. It belongs to antihypertensive / antianginal category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Pyridoxine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes pyridoxine HCI. It belongs to vit. B6 deficiency category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Salbutamol Sulphate

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes salbutamol sulphate. It belongs to bronchodilator category. Bulk physical form: pellets, resinates. Final dosage form: caps/tabs. Contact us for more information.

Compare
Product Simvastatine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes simvastatine. It belongs to hyperlipidemia / hyperchole category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Theophylline

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes theophylline. It belongs to bronchodilator category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Tizanidine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes tizanidine HCI. It belongs to muscle relaxant category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Trifluoperazine HCI

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trifluoperazine HCI. It belongs to antipsychotic category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Trihexyphenidyl HCl

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trihexyphenidyl HCl. It belongs to anticholinergic / antiparkinsonian category. Bulk physical form: pellets. Final dosage form: caps. Contact us for more information.

Compare
Product Trimetazidine

Osmopharm S.A. studies, develops and produces modified release forms under contract manufacturing which includes trimetazidine. It belongs to antianginal category. Bulk physical form: powder. Final dosage form: caps/tabs. Contact us for more information.

Compare

CPHI Online is the largest global marketplace in the pharma ingredients industry

Osmopharm S.A.

About Osmopharm S.A.

Sales Markets

Categories

Products from Osmopharm S.A. (100)

Position your company at the heart of the global Pharma industry with a CPHI Online membership

Coming soon

Osmopharm S.A.

Address

Telephone

Website

Request for general information

Send a message to Please review your profile details to ensure it is up-to-date.

Send a message to
Please review your profile details to ensure it is up-to-date.